Article Versions Notes

Al Khzem AH, Alturki MS, Almuzaini OK, Wali SM, Almaghrabi M, Aldawsari MF, Abduljabbar MH, Alnemari RM, Almalki AH, Rants’o TA. Isoetin from Isoetaceae Exhibits Superior Pentatransferase Inhibition in Breast Cancer: Comparative Computational Profiling with FDA-Approved Tucatinib. Pharmaceuticals. 2025; 18(5):662. https://doi.org/10.3390/ph18050662

Al Khzem, Abdulaziz H., Mansour S. Alturki, Ohood K. Almuzaini, Saad M. Wali, Mohammed Almaghrabi, Mohammed F. Aldawsari, Maram H. Abduljabbar, Reem M. Alnemari, Atiah H. Almalki, and Thankhoe A. Rants’o. 2025. "Isoetin from Isoetaceae Exhibits Superior Pentatransferase Inhibition in Breast Cancer: Comparative Computational Profiling with FDA-Approved Tucatinib" Pharmaceuticals 18, no. 5: 662. https://doi.org/10.3390/ph18050662

Al Khzem, A. H., Alturki, M. S., Almuzaini, O. K., Wali, S. M., Almaghrabi, M., Aldawsari, M. F., Abduljabbar, M. H., Alnemari, R. M., Almalki, A. H., & Rants’o, T. A. (2025). Isoetin from Isoetaceae Exhibits Superior Pentatransferase Inhibition in Breast Cancer: Comparative Computational Profiling with FDA-Approved Tucatinib. Pharmaceuticals, 18(5), 662. https://doi.org/10.3390/ph18050662